1. Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
   Getinet M. Adinew et al, 2021, Nutrients CrossRef
2. Identification and Validation of Hub Genes for Predicting Treatment Targets and Immune Landscape in Rheumatoid Arthritis
   Xinling He et al, 2022, BioMed Research International CrossRef
3. Transcriptomics and experimental validation-based approach to understand the effect and mechanism of Huangqin tang interfeience with colitis associated colorectal cancer
   Xuran Ma et al, 2023, Heliyon CrossRef
4. RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15
   Hao Ding et al, 2023, Molecules and Cells CrossRef
5. Comprehensive pan-carcinoma analysis of ITGB1 distortion and its potential clinical significance for cancer immunity
   Yuchang Fei et al, 2024, Discover Oncology CrossRef
6. Exploiting LRRC15 as a Novel Therapeutic Target in Cancer
   Upasana Ray et al, 2022, Cancer Research CrossRef
7. Stromal cells in the tumor microenvironment: accomplices of tumor progression?
   Yan Zhao et al, 2023, Cell Death & Disease CrossRef
8. LRRC15 expression indicates high level of stemness regulated by TWIST1 in mesenchymal stem cells
   Kensuke Toriumi et al, 2023, iScience CrossRef
9. Exploring Tumor-Promoting Qualities of Cancer-Associated Fibroblasts and Innovative Drug Discovery Strategies With Emphasis on Thymoquinone
   Jabir Padathpeedika Khalid et al, 2024, Cureus CrossRef